Rosara Bass
Overview
Explore the profile of Rosara Bass including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bass R, Alvarez J
Pediatr Pulmonol
. 2024 Aug;
59 Suppl 1:S6-S16.
PMID: 39105341
Advances in cystic fibrosis (CF) diagnostics and therapeutics have led to improved health and longevity, including increased body weight and decreased malnutrition in people with CF. Highly effective CFTR modulator...
2.
Grant L, Collins E, Zur K, Bass R, Phinizy P, Piccione J
Pediatr Pulmonol
. 2024 Jul;
59(11):2850-2856.
PMID: 39031760
Background: The aim of our study was to investigate the prevalence of coexisting conditions and exposures in children with nodular tracheobronchitis diagnosed by flexible bronchoscopy. Methods: We conducted a single-center...
3.
Bass R, Ren C, Kordunova D, Schindler T, Salzedo S, Omori M, et al.
J Cyst Fibros
. 2024 Jul;
23(4):771-773.
PMID: 38997824
No abstract available.
4.
Tindall A, Bass R, Maqbool A, Stallings V
J Cyst Fibros
. 2024 May;
23(4):758-763.
PMID: 38789320
Background: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators improve nutritional status and are of importance in achieving normal growth among younger children with CF. The study was designed to examine...
5.
Baccarella A, Lee C, Bass R, Quinn S
NEJM Evid
. 2024 Feb;
2(2):EVIDmr2200308.
PMID: 38320037
A 12-Year-Old Girl with Weight LossThis report examines a case of chronic weight loss, anxiety, abdominal pain, and nausea in an adolescent girl. With directed questioning, physical examination, and testing,...
6.
Changes in fecal lipidome after treatment with ivacaftor without changes in microbiome or bile acids
Bass R, Tanes C, Bittinger K, Li Y, Lee H, Friedman E, et al.
J Cyst Fibros
. 2023 Oct;
23(3):481-489.
PMID: 37813785
Background: Alterations in gastrointestinal health are prominent manifestations of cystic fibrosis (CF) and can independently impact pulmonary function. Ivacaftor has been associated with robust improvements in pulmonary function and weight...
7.
Bass R, Mascarenhas M, Kelly A, Mousa H
Pediatr Pulmonol
. 2023 Sep;
58(12):3637-3640.
PMID: 37737463
No abstract available.
8.
Tindall A, Bass R, Maqbool A, Stallings V
J Cyst Fibros
. 2023 Jul;
22(6):989-995.
PMID: 37438197
Background: Highly effective CFTR modulators improve nutritional status and are of particular importance among younger children experiencing rapid growth. This study was designed to examine CFTR modulator associated changes in...
9.
Bass R, Brownell J, Stallings V
Nutrients
. 2021 Sep;
13(9).
PMID: 34578785
Patients with cystic fibrosis (CF) are at increased risk of malnutrition and growth failure due to multiple factors as a result of suboptimal or absent function of the CFTR chloride...
10.
Beal E, Bass R, Harzman A
Case Rep Surg
. 2015 Dec;
2015:957257.
PMID: 26682082
Introduction. Clostridium difficile is the most common cause of healthcare associated infectious diarrhea, and its most common clinical manifestation is pseudomembranous colitis. Small bowel enteritis is reported infrequently in the...